Cancer Invasion: Patterns and Mechanisms NV Krakhmal, MV Zavyalova, EV Denisov, SV Vtorushin, VM Perelmuter Acta Naturae 7 (2), 17-28, 2015 | 473 | 2015 |
Mutational drivers of cancer cell migration and invasion NM Novikov, SY Zolotaryova, AM Gautreau, EV Denisov British Journal of Cancer 124 (1), 102-114, 2021 | 164 | 2021 |
Intratumor heterogeneity: nature and biological significance TS Gerashchenko, ЕV Denisov, NV Litviakov, MV Zavyalova, ... Biochemistry (Moscow) 78 (11), 1201-1215, 2013 | 164* | 2013 |
Intravasation as a key step in cancer metastasis MV Zavyalova, EV Denisov, LA Tashireva, OE Savelieva, EV Kaigorodova, ... Biochemistry (Moscow) 84 (7), 762-772, 2019 | 96 | 2019 |
Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response NV Litviakov, NV Cherdyntseva, MM Tsyganov, EV Denisov, EY Garbukov, ... Cancer chemotherapy and pharmacology 71 (1), 153-163, 2013 | 89 | 2013 |
Cortical branched actin determines cell cycle progression N Molinie, SN Rubtsova, A Fokin, SP Visweshwaran, N Rocques, ... Cell research 29 (6), 432-445, 2019 | 73 | 2019 |
The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis MV Zavyalova, VM Perelmuter, SV Vtorushin, EV Denisov, NV Litvyakov, ... Diagnostic Cytopathology 41 (3), 279–282, 2013 | 71 | 2013 |
Markers of Cancer Cell Invasion: Are They Good Enough? TS Gerashchenko, NM Novikov, NV Krakhmal, SY Zolotaryova, ... Journal of Clinical Medicine 8 (8), 1092, 2019 | 68 | 2019 |
Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression EV Denisov, NV Litviakov, MV Zavyalova, VM Perelmuter, SV Vtorushin, ... Scientific reports 4, 2014 | 68 | 2014 |
The phenomenon of multi-drug resistance in the treatment of malignant tumors SV Vtorushin, KY Khristenko, MV Zavyalova, VM Perelmuter, NV Litviakov, ... Exp Oncol 36 (3), 144-56, 2014 | 57 | 2014 |
Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity TS Gerashchenko, MV Zavyalova, EV Denisov, NV Krakhmal, ... Acta Naturae 9 (1), 56, 2017 | 56* | 2017 |
Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal … EV Denisov, NA Skryabin, TS Gerashchenko, LA Tashireva, J Wilhelm, ... Oncotarget, 2017 | 54 | 2017 |
Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified MV Zavyalova, EV Denisov, LA Tashireva, TS Gerashchenko, ... BioResearch Open Access 2 (2), 148-154, 2013 | 49 | 2013 |
MT1-MMP targeting to endolysosomes is mediated by upregulation of flotillins D Planchon, E Rios Morris, M Genest, F Comunale, S Vacher, I Bièche, ... Journal of cell science 131 (17), jcs218925, 2018 | 44 | 2018 |
Types of immune-inflammatory responses as a reflection of cell–cell interactions under conditions of tissue regeneration and tumor growth LA Tashireva, VM Perelmuter, VN Manskikh, EV Denisov, OE Savelieva, ... Biochemistry (Moscow) 5 (82), 542-555, 2017 | 43* | 2017 |
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds ME Menyailo, MS Tretyakova, EV Denisov Int. J. Mol. Sci 21, 1696, 2020 | 40 | 2020 |
Invasive and drug resistant expression profile of different morphological structures of breast tumors EV Denisov, TS Gerashchenko, MV Zavyalova, NV Litviakov, ... Neoplasma 62 (3), 405-411, 2015 | 39 | 2015 |
Age-related function of tumor suppressor gene TP53: contribution to cancer risk and progression NV Cherdyntseva, PA Gervas, NV Litvyakov, MN Stakcheeva, ... exp. oncol 32 (3), 205-208, 2010 | 39 | 2010 |
Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer EV Kaigorodova, OE Savelieva, LA Tashireva, NA Tarabanovskaya, ... Molecules 23 (4), 727, 2018 | 38 | 2018 |
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes M Zavyalova, S Vtorushin, N Telegina, N Krakhmal, O Savelieva, ... Experimental Oncology 38 (2), 122-127, 2016 | 35 | 2016 |